Wells Fargo’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.6K Buy
24,139
+3,055
+14% +$23K ﹤0.01% 5557
2026
Q2
$307K Buy
+21,084
New +$269K ﹤0.01% 4928
2024
Q2
– Sell
-2
Closed -$8 – 7449
2024
Q1
$8 Hold
2
– – ﹤0.01% 7336
2023
Q4
$51 Hold
2
– – ﹤0.01% 6928
2023
Q3
$48 Hold
2
– – ﹤0.01% 6929
2023
Q2
$47 Buy
2
+1
+100% +$27 ﹤0.01% 7070
2023
Q1
$30 Buy
+1
New +$104 ﹤0.01% 7263
2022
Q4
– Hold
0
– – – 7185
2022
Q3
– Hold
0
– – – 7353
2022
Q2
– Hold
0
– – – 7476
2022
Q1
– Hold
0
– – – 7798
2021
Q4
– Hold
0
– – – 7796
2021
Q3
– Hold
0
– – – 7510
2021
Q2
– Hold
0
– – – 7429
2021
Q1
– Hold
0
– – – 7364
2020
Q4
– Hold
0
– – – 7014
2020
Q3
– Hold
0
– – – 6892
2020
Q2
– Hold
0
– – – 6813
2020
Q1
– Hold
0
– – – 6786
2019
Q1
– Hold
0
– – – 6441
2018
Q4
– Hold
0
– – – 6606
2018
Q3
– Hold
0
– – – 6562
2018
Q2
– Hold
0
– – – 6565
2018
Q1
– Hold
0
– – – 6565
2017
Q4
– Hold
0
– – – 6518
2017
Q3
– Hold
0
– – – 6462
2017
Q2
– Hold
0
– – – 6446
2017
Q1
– Hold
0
– – – 6493
2016
Q4
– Hold
0
– – – 6443
2016
Q3
– Hold
0
– – – 6334
2016
Q2
– Hold
0
– – – 6320
2016
Q1
– Hold
0
– – – 6417
2015
Q4
– Hold
0
– – – 6407
2015
Q3
– Hold
0
– – – 6440
2015
Q2
– Hold
0
– – – 6508
2015
Q1
– Hold
0
– – – 6356
2014
Q4
– Hold
0
– – – 6404
2014
Q3
– Hold
0
– – – 6340
2014
Q2
– Hold
0
– – – 6278
2014
Q1
– Hold
0
– – – 5639
2013
Q4
– Hold
0
– – – 5919
2013
Q3
– Hold
0
– – – 5836
2013
Q2
– Hold
0
– – – 5696

Other funds holding TENX

Wells Fargo's TENX Position: Q3 2026 in Review

Wells Fargo increased its Tenax Therapeutics (TENX) stake by 14% in Q3 2026, buying an estimated $23K and bringing the position to 24,139 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5557.

Wells Fargo first reported a position in TENX in Q1 2023 and has held it in 7 quarters since. The position peaked at $307K in Q2 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • Wells Fargo held 24,139 shares of Tenax Therapeutics worth $45.6K as of Q3 2026.
  • Wells Fargo bought 3,055 Tenax Therapeutics shares in Q3 2026, an estimated $23K.
  • Tenax Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5557 holding.
  • Wells Fargo first reported a position in Tenax Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • Wells Fargo's Tenax Therapeutics position peaked at $307K in Q2 2026.
  • 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.